CLBT Stock - Cellebrite DI Ltd.
Unlock GoAI Insights for CLBT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $401.20M | $325.11M | $270.65M | $246.25M | $194.91M |
| Gross Profit | $338.61M | $271.88M | $219.91M | $203.69M | $157.03M |
| Gross Margin | 84.4% | 83.6% | 81.3% | 82.7% | 80.6% |
| Operating Income | $56.91M | $33.24M | $1.04M | $13.82M | $9.22M |
| Net Income | $-283,007,000 | $-81,100,000 | $120.81M | $71.40M | $5.78M |
| Net Margin | -70.5% | -24.9% | 44.6% | 29.0% | 3.0% |
| EPS | $-1.35 | $-0.43 | $0.64 | $0.50 | $0.03 |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| March 28th 2024 | Needham | Reiterated | Buy | $13.5← $13 |
| March 13th 2024 | William Blair | Upgrade | Outperform | - |
| February 16th 2024 | BofA Securities | Upgrade | Buy | $12← $9 |
| July 19th 2023 | Craig Hallum | Initiation | Buy | $11 |
| August 12th 2022 | BofA Securities | Downgrade | Neutral | $6← $6.5 |
| August 12th 2022 | William Blair | Downgrade | Market Perform | - |
Earnings History & Surprises
CLBTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | $0.14 | — | — | — |
Q4 2025 | Nov 12, 2025 | $0.09 | $0.14 | +48.2% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $0.10 | $0.12 | +20.0% | ✓ BEAT |
Q2 2025 | May 14, 2025 | $0.05 | $0.10 | +90.3% | ✓ BEAT |
Q1 2025 | Feb 13, 2025 | $0.10 | $0.10 | 0.0% | = MET |
Q4 2024 | Nov 6, 2024 | $0.11 | $0.14 | +27.3% | ✓ BEAT |
Q3 2024 | Aug 15, 2024 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Q2 2024 | May 23, 2024 | $0.06 | $0.08 | +45.5% | ✓ BEAT |
Q1 2024 | Feb 15, 2024 | $0.06 | $0.11 | +83.3% | ✓ BEAT |
Q4 2023 | Nov 14, 2023 | $0.04 | $0.09 | +118.9% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $0.02 | $0.05 | +114.3% | ✓ BEAT |
Q2 2023 | May 10, 2023 | $0.02 | $0.03 | +77.8% | ✓ BEAT |
Q1 2023 | Feb 15, 2023 | $0.06 | $0.08 | +33.3% | ✓ BEAT |
Q4 2022 | Nov 17, 2022 | $0.02 | $0.01 | -55.6% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | — | $0.17 | — | — |
Q2 2022 | May 12, 2022 | $0.02 | $0.01 | -55.6% | ✗ MISS |
Q1 2022 | Feb 16, 2022 | $0.02 | $0.03 | +33.3% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $0.02 | $0.08 | +300.0% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $0.05 | $0.04 | -16.7% | ✗ MISS |
Latest News
JP Morgan Maintains Overweight on Cellebrite DI, Raises Price Target to $24
📈 PositiveLake Street Maintains Buy on Cellebrite DI, Raises Price Target to $23
📈 PositiveB of A Securities Maintains Buy on Cellebrite DI, Raises Price Target to $25
📈 PositiveCellebrite DI shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
📈 PositiveNeedham Maintains Buy on Cellebrite DI, Raises Price Target to $24
📈 PositiveCellebrite Non-GAAP EPS of $0.14 beats by $0.01, revenue of $126.03M beats by $3.05M
📈 PositiveCellebrite DI shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
📈 PositiveCellebrite DI Raises FY2025 Sales Guidance from $465.000M-$475.000M to $470.000M-$475.000M vs $469.411M Est
📈 PositiveCellebrite DI Sees Q4 Sales $123.000M-$128.000M vs $125.296M Est
➖ NeutralCellebrite DI Q3 Adj. EPS $0.14 Beats $0.13 Estimate, Sales $126.029M Beat $122.014M Estimate
📈 PositiveJP Morgan Maintains Overweight on Cellebrite DI, Raises Price Target to $23
📈 PositiveFrequently Asked Questions about CLBT
What is CLBT's current stock price?
What is the analyst price target for CLBT?
What sector is Cellebrite DI Ltd. in?
What is CLBT's market cap?
Does CLBT pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to CLBT for comparison